Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$2,682 Mln
Revenue (TTM)
$2,123 Mln
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
120.4
P/B Ratio
3.6
Industry P/E
--
EV/EBITDA
50.1
Div. Yield
0 %
Debt to Equity
0
Book Value
$5670.9
EPS
$0.2
Face value
--
Shares outstanding
123,688,289
CFO
$254.75 Mln
EBITDA
$-154.40 Mln
Net Profit
$-143.19 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Privia Health Group (PRVA)
| -8.0 | 0.2 | -8.9 | -7.6 | -6.9 | -- | -- |
|
BSE Sensex
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Privia Health Group (PRVA)
| 21.3 | -15.0 | 1.4 | -12.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Privia Health Group (PRVA)
|
21.8 | 2,681.6 | 2,122.8 | 22.9 | 1.9 | 0 | 120.4 | 3.6 |
| 14.3 | 3,315.2 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 381.9 | 5,670.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 21.9 | 5.6 | |
| 54.1 | 2,697.1 | 941.5 | 105.7 | 14.5 | 29.4 | 25.8 | 7.2 | |
| 97.9 | 10,098.8 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.1 | 4.1 | |
| 23.5 | 5,434.1 | 2,347.6 | 128.4 | 4.9 | 25.2 | 46.7 | 10.0 | |
| 29.5 | 4,649.3 | 5,649.5 | 207.6 | 7.0 | 15.2 | 23.1 | 3.5 | |
| 61.9 | 4,818.9 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.4 | |
| 13.5 | 3,815.1 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.7 | 6.3 | |
| 204.5 | 12,186.8 | 5,057.8 | 344.0 | 9.2 | 16.9 | 36 | 5.5 |
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance... providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia. Read more
CEO & Director
Mr. Parth Mehrotra
CEO & Director
Mr. Parth Mehrotra
Headquarters
Arlington, VA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Privia Health Group Inc (PRVA) is $21.82 (NASDAQ) as of 19-Mar-2026 10:35 EDT. Privia Health Group Inc (PRVA) has given a return of -6.95% in the last 3 years.
The P/E ratio of Privia Health Group Inc (PRVA) is 120.44 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
134.49
|
0.00
|
|
2024
|
171.24
|
3.88
|
|
2023
|
124.73
|
5.13
|
|
2022
|
-293.63
|
5.05
|
|
2021
|
-14.16
|
6.24
|
The 52-week high and low of Privia Health Group Inc (PRVA) are Rs 26.51 and Rs 18.77 as of 19-Mar-2026.
Privia Health Group Inc (PRVA) has a market capitalisation of $ 2,682 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Privia Health Group Inc (PRVA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.23
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.